Morgan Stanley Institutional Fund, Inc. Growth Portfolio

Scorecard
5 / 5 Stars
Lipper
5 5 3 4 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A (Buy)

U.S. News evaluated 466 Large Growth Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Morgan Stanley funds

See full Large Growth rankings

See more fund rankings

Performance

The fund has returned 52.66 percent over the past year, 19.05 percent over the past three years, 30.40 percent over the past five years, and 10.57 percent over the past decade.

Trailing Returns Updated 02.28.2014
Year to date 6.2%
1 Year 52.7%
3 Years (Annualized) 19.0%
5 Years (Annualized) 30.4%
10 Years (Annualized) 10.6%

See more MSEQX performance

Summary

The investment seeks long-term capital appreciation by investing primarily in growth-oriented equity securities of large capitalization companies. The fund invests primarily in established and emerging companies, with capitalizations within the range of companies included in the Russell 1000® Growth Index. It may invest up to 25% of the Portfolio's net assets in foreign securities. The fund may utilize foreign currency forward exchange contracts, which are derivatives, in connection with its investments in foreign securities.

Fees

Fees are Average compared to funds in the same category.
Morgan Stanley Institutional Fund, Inc. Growth Portfolio has an expense ratio of 0.72 percent.

See more MSEQX fees

Risk

Risk is High compared to funds in the same category according to Morningstar.

See more MSEQX risk